Recombinant Anti-AR x Anti-DNA Bispecific Antibody (IgG-Fv) (BSGV-012)

Recombinant Anti-AR x Anti-DNA Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-AR antibody variable domain is fused to the C terminal of an IgG of anti-DNA antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can enter prostate cancer cells and inhibits androgen receptor function. It is designed for the research of prostate cancer therapy.

Datasheet INQUIRY

Specifications

Targets

AR & DNA

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Prostate cancer

Targets

Target 1

Gene ID

367

UniProt ID

P10275

Alternative Names

AR; androgen receptor; KD; AIS; TFM; DHTR; SBMA; HYSP1; NR3C4; SMAX1; HUMARA; dihydrotestosterone receptor; androgen nuclear receptor variant 2; nuclear receptor subfamily 3 group C member 4

Target 2

DNA

Alternative Names

DNA; Deoxyribonucleic acid

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-AR x Anti-DNA Bispecific Antibody (IgG-Fv) (BSGV-012). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-AR x Anti-DNA Bispecific Antibody (IgG-Fv) (CAT#: BSGV-012)

Specifications

Targets

Customer Reviews and Q&As